|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Oxurion NV |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Protara Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Akoya Biosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Oryzon Genomics, S.A. |
Oryzon Genomics, S.A. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Taysha Gene Therapies, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Lipella Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Protara Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Protara Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
IO Biotech, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
PharmAla Biotech |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
IR-MED Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Sanara MedTech Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Praxis Precision Medicines, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
NGM Biopharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
BioPorto Diagnostics A/S |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Theratechnologies Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
PHAXIAM Therapeutics S.A. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Apr 2024
|
Related companies:
Euroapi SAS |
|